Volume : 13, Issue : 04, April – 2026

Title:

EMERGING TRENDS IN DERMATOLOGICAL INFECTIONS:A COMPREHENSIVE REVIEW

Authors :

S.M. Shahidulla, M. Suresh Babu, Mariyam Fathima*, Rumaisa Afsheen, Akifa Mustafa Hussain

Abstract :

Skin illnesses develop when the normal structure or appropriate function of the skin and its layers is compromised. These conditions can affect anyone of any age, gender, race, or socioeconomic status. Among the most common skin conditions affecting a substantial portion of the global population are dry skin, acne, and hyperpigmentation. Additionally, it explains the skin’s anatomy, highlighting the dermis and epidermis, the skin turnover process, and mechanical properties, including strain, stress, and absorption. Dry skin has received the greatest attention in the literature, consistent with earlier findings. Among the several diagnostic techniques used to identify skin disorders are skin Wood’s lamp examination, microbial culture, biopsy, diascopy, and other specialised dermatological procedures.
Skin diseases are treated with both pharmaceutical and physical therapy. Medical treatment includes both topical therapies that are applied directly to the skin and systemic medications. Physical treatment methods include cryotherapy, phototherapy, photodynamic therapy, laser therapy, and surgical procedures. Topical medications are the primary treatment for many skin conditions. Conversely, systemic medications are administered orally or parenterally, enabling systemic distribution throughout the body.
Keywords: Skin disorders, bacterial, viral, fungal, treatment, skin anatomy, acne skin, dry skin

Cite This Article:

Please cite this article in press Mariyam Fathima et al., Emerging trends in dermatological infections:A comprehensive review., Indo Am. J. P. Sci, 2026; 13(04).

REFERENCES:

1. Jackson LA, Hunter JE, Hodge CN (1995) Physical attractiveness and intellectual competence: A meta-analytic review. Social Psychology Quarterly 58: 108-122.
2. Tews MJ, Stafford K, Zhu J (2009) Beauty revisited: The impact of attractiveness, ability, and personality in the assessment of employment suitability. Int J Select Assess 17: 92-100.
3. Mobius MM, Rosenblat TS (2006) Why beauty matters. The American Economic Review 96: 222-235.
4. Benzeval M, Green MJ, Macintyre S (2013) Does perceived physical attractiveness in adolescence predict better socioeconomic position in adulthood? Evidence from 20 Years of follow up in a population cohort study. PLoS One 8.
5. Judge TA, Hurst C, Simon L (2009) Does it pay to be smart, attractive, or confident (or all three) Relationships among general mental ability, physical attractiveness, core self evaluations, and income. JAP 94: 742-755.
6. Watkins LM, Johnston L (2000) Screening job applicants: The impact of physical attractiveness and application quality. Int J Select Assess 8: 76-84.
7. Tanese, K. Diagnosis and Management of Basal Cell Carcinoma. Curr. Treat. Options Oncol. 2019, 20, 13.
8. Howell, J.Y.; Ramsey, M.L. Squamous Cell Skin Cancer; StatPearls Publishing: Treasure Island, FL, USA, 2023. Available online: https://www.ncbi.nlm.nih.gov/books/NBK441939/ (accessed on 4 November 2023).
9. Guo, W.; Wang, H.; Li, C. Signal pathways of melanoma and targeted therapy. Signal Transduct. Target. Ther. 2021, 6, 424.
10. Patel, P.; Hussain, K. Merkel cell carcinoma. Clin. Exp. Dermatol. 2021, 46, 814–819.
11. Mistry, K.; Levell, N.J.; Hollestein, L. Trends in incidence, treatment and survival of Merkel cell carcinoma in England 2004–2018: Acohort study. Br. J. Dermatol. 2023, 188, 228–236.
12. Dummer,R.; Vermeer, M.H.; Scarisbrick, J.J. Cutaneous T cell lymphoma. Nat. Rev. Dis. Primers 2021, 7, 61.
13. Goodlad, J.R.; Cerroni, L.; Swerdlow, S.H. Recent advances in cutaneous lymphoma-implications for current and future classifications. Virchows Arch. 2023, 482, 281–298.
14. Varadé J, Magadán S, González-Fernández Á. Human immunology and immunotherapy: Main achievements and challenges. Cell Mol Immunol. 2021;18:805-28.
15. Joly P, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, et al. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): A prospective, multicentre, parallel-group, open-label randomised trial. Lancet. 2017;389:2031-40.
16. Roostaeyan O, Kivelevitch D, Menter A. A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis. Immunotherapy. 2017;9:963-78.
17. Yan D, Gudjonsson JE, Le S, Maverakis E, Plazyo O, Ritchlin C, et al. New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision Medicine. J. Investig. Dermatol. 2021;141:2112-22.e3.
18. Habif TP. Psoriasis and other papulosquamous diseases. In: Clinical Dermatology. 5th ed. Hanover, N.H.: Mosby Elsevier; 2010:264-75.
19. Hsu S, Papp KA, Lebwohl MG, et al; National Psoriasis Foundation Medical Board. Consensus guidelines for the management of plaque psoriasis. Arch Dermatol. 2012;148(1):95-102.
20. Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009;61(3):451-85.
21. Picardo M, Dell’Anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D, et al. Vitiligo. Nat Rev Dis Primers. 2015;1(1):15011.
22. Gandhi K, Ezzedine K, Anastassopoulos KP, Patel R, Sikirica V, Daniel SR, Napatalung L, Yamaguchi Y, Baik R, Pandya AG. Prevalence of vitiligo among adults in the United States. JAMA dermatology. 2022;158(1):43-50.